COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,693 Articles (22,913 medRxiv, 8,780 bioRxiv)

Most recent first Previous |  Page 640: Articles 6391-6400  | Next

Safety and effectiveness of COVID-19 mRNA vaccination and risk factors for hospitalisation caused by the omicron variant in 0.8 million adolescents: A nationwide cohort study in Sweden
Nordström, P., Ballin, M., Nordström, A.
10.1101/2022.10.19.22281286 — Posted: 2022-10-21
Uptake of COVID-19 vaccines among healthcare workers within primary healthcare facilities, Entebbe municipality Uganda
Kyakuwa, N., Atuhairwe, C., Kalutte, H., Mpooya, S., Nakanjako, F., Perez, L., Kikaire, B.
10.1101/2022.10.20.22281300 — Posted: 2022-10-21
Encoding generation time changes within reproduction numbers
Parag, K. V., Cowling, B., Lambert, B. C.
10.1101/2022.10.19.22281255 — Posted: 2022-10-21
Evidence of a Sjogrens disease-like phenotype following COVID-19
Yiran, S., Voigt, A., Goranova, L., Abed, M., Kleiner, D., Maldonado, J., Beach, M., Pelayo, E., Chiorini, J., Craft, W., Ostrov, D., Ramiya, V., Sukumaran, S., Tuanyok, A., Warner, B., Nguyen, C.
10.1101/2022.10.20.22281265 — Posted: 2022-10-21
Prediction of COVID-19 Diagnosis from Healthy and Pneumonia CT scans using Convolutional Neural Networks
Srirambhatla, R., Karim, H. T.
10.1101/2022.10.20.22281334 — Posted: 2022-10-21
The COVID-19 burnout scale: Development and initial validation
Galanis, P. A., Katsiroumpa, A., Sourtzi, P., Siskou, O., Konstantakopoulou, O., Kaitelidou, D.
10.1101/2022.10.20.22281317 — Posted: 2022-10-21
Deep reinforcement learning framework for controlling infectious disease outbreaks in the context of multi-jurisdictions
khatami, S. N., Gopalappa, C.
10.1101/2022.10.18.22281063 — Posted: 2022-10-21
Parental Preferences and Reasons for COVID-19 Vaccination Among Their Children
Sehgal, N., Rader, B., Gertz, A., Astley, C. M., Brownstein, J. S.
10.1101/2022.10.20.22281313 — Posted: 2022-10-21
Dynamics of non-household contacts during the COVID-19 pandemic in 2020 and 2021 in the Netherlands
Backer, J. A., Bogaardt, L., Beutels, P., Coletti, P., Edmunds, J., Gimma, A., van Hagen, C. C. E., Hens, N., Jarvis, C. I., Vos, E. R. A., Wambua, J., Wong, D., van Zandvoort, K., Wallinga, J.
10.1101/2022.10.19.22281248 — Posted: 2022-10-21
Investigating SARS-CoV-2 infection and the health and psychosocial impact of the COVID-19 pandemic in the Canadian CHILD Cohort study: methodology and cohort profile
Azeez, R., Lotoski, L., Dubeau, A., Rodriguez, N., Reyna, M. E., Freitas, T., Goguen, S., Medeleanu, M., Winsor, G. L., Brinkman, F. S. L., Cameron, E. E., Roos, L., Simons, E., Moraes, T. J., Mandhane, P. J., Turvey, S. E., Bolotin, S., Wright, K., McNeil, D., Patrick, D. M., Bullard, J., Langlois, M.-A., Arnold, C. R., Galipeau, Y., Pelchat, M., Doucas, N., Subbarao, P., Azad, M. B.
10.1101/2022.10.19.22281242 — Posted: 2022-10-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).